Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Smart Life Sciences Manufacturing Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The smart life sciences manufacturing market has experienced rapid expansion in its size over recent years. Forecasts indicate it will expand from $28.59 billion in 2025 to reach $32.83 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 14.8%. Historically, this growth can be ascribed to several factors, including the increasing intricacy of life sciences manufacturing processes, heightened regulatory oversight on product quality, an expansion in pharmaceutical and biopharma production capabilities, the early implementation of automation technologies, and a rising need for manufacturing traceability.
The smart life sciences manufacturing market is anticipated to experience substantial expansion over the next few years. It is projected to reach $59.21 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.9%. This projected growth can be attributed to several factors, including increasing investments in smart pharma factories, the rising adoption of digital twin technologies, the expansion of personalized medicine manufacturing, the growing integration of AI-driven quality analytics, and an increasing focus on supply chain visibility and resilience. Furthermore, key trends for the forecast period include the increasing adoption of digital manufacturing execution systems, a rising integration of IoT-enabled production monitoring, the growing use of advanced data analytics for process optimization, the expansion of automation and robotics in pharma manufacturing, and an enhanced focus on regulatory compliance and quality control.
Download A Free Sample Report For Comprehensive Market Insights:
#Smart Life Sciences Manufacturing Market Growth Factors: Which Forces Are Supporting Market Expansion?
The increasing need for personalized medicine is projected to drive the expansion of the smart life sciences manufacturing market moving forward. Personalized medicine defines a medical and healthcare strategy that customizes decisions, practices, interventions, and therapies for individual patients. This escalating demand for personalized medicine compels the life sciences industry to integrate smart manufacturing technologies and processes. This integration facilitates the efficient, precise, and adaptable production of tailor-made pharmaceuticals and therapies, consequently enhancing treatment outcomes. A relevant example is from February 2024, where the Personalized Medicine Coalition, a US-based non-profit entity, reported that in 2023, the FDA sanctioned 16 novel personalized treatments for rare disease patients, marking an increase from six in 2022. Additionally, the personalized treatments newly approved in 2023 encompassed seven cancer drugs and three for other diseases and conditions. Consequently, the growing requirement for personalized medicine is fueling the growth of the smart life sciences manufacturing market.
Smart Life Sciences Manufacturing Market Segment Analysis: What Are The Major Market Categories?
The smart life sciences manufacturing market covered in this report is segmented –
1) By Component: Solution, Services
2) By Technology: Internet of Things (IoT), Artificial Intelligence, Cybersecurity, Big Data, Other Technologies
3) By Application: Pharma, Bio-Pharma, Medical Device
Subsegments:
1) By Solution: Manufacturing Execution Systems (MES), Quality Management Systems (QMS), Automation and Control, Data Analytics And Reporting
2) By Services: Consulting Services, Integration And Implementation, Maintenance and Support
Smart Life Sciences Manufacturing Market Innovation Trends: Which Developments Are Transforming The Industry?
Leading industry players are directing their efforts towards creating innovative artificial intelligence (AI) medical technologies to sustain their market presence. AI-based advancements are crucial in smart life science for analyzing and interpreting vast datasets, streamlining processes, and enabling more personalized engagement. For instance, in May 2023, Google Cloud Platform LLC, a US-based technology company, unveiled two new AI-powered solutions designed to accelerate drug discovery and precision medicine. These innovative tools are capable of helping researchers discover new drugs more quickly and efficiently. Additionally, these tools can help enhance the accuracy of drug development and reduce the costs involved in bringing new drugs to market. Furthermore, they hold the potential to accelerate the growth of new drugs and improve patients’ lives.
Smart Life Sciences Manufacturing Market Leading Companies Driving Competitive Growth
Major companies operating in the smart life sciences manufacturing market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Novartis AG, Merck and Co Inc, Sanofi S A, GlaxoSmithKline plc, AstraZeneca plc, Bristol Myers Squibb, Eli Lilly and Company, AbbVie Inc, Amgen Inc, Gilead Sciences Inc, Biogen Inc, Takeda Pharmaceutical Company Limited, Bayer AG, Boehringer Ingelheim, Novo Nordisk A S, Teva Pharmaceutical Industries Ltd, CSL Limited
Access The Complete Smart Life Sciences Manufacturing Market Report:
Smart Life Sciences Manufacturing Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the smart life sciences manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart life sciences manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.